App-Based diabetes coaching shows promise in small trial

NCT ID NCT07513961

Completed Disease control Sponsor: Alanya Alaaddin Keykubat University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether a nurse-led mobile app could improve diabetes management in 112 adults with type 2 diabetes. The intervention group received structured education and reminders via the app for 6 months, while the control group got standard care. The main goal was to see if the app helped lower blood sugar levels (HbA1c) and improve self-care behaviors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Technology-Based Diabetes Education and Follow-up System (PAS-DM) - a mobile health platform providing structured education and reminders
What this could lead to: If successful, this approach could offer a scalable, low-cost way to help people with type 2 diabetes better manage their condition at home.
What could go wrong: This is a completed trial with 112 participants, so results are limited in size. The intervention requires a smartphone and internet, which may not be available to everyone. It focuses on education, not a new drug or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES SELF-MANAGEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES SELF-MANAGEMENT GLYCEMIC CONTROL TYPE 2 DIABETES MELLITUS (T2DM)

Contacts and locations

Locations

Alanya Alaaddin Keykubat University Training and Research Hospital, Department of Internal Medicine

Alanya, Antalya, 07400, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.